Anesthetic Management of Atypical Toxic Epidermal Necrolysis in a Six-Month-Old Patient Undergoing Burn Surgery: A Case Report
- PMID: 40502904
- PMCID: PMC12153406
- DOI: 10.7759/cureus.83952
Anesthetic Management of Atypical Toxic Epidermal Necrolysis in a Six-Month-Old Patient Undergoing Burn Surgery: A Case Report
Abstract
Toxic epidermal necrolysis (TEN) is a rare, life-threatening skin condition that involves widespread skin detachment and mucous membrane damage. We present a case of a six-month-old male with atypical TEN transferred from an outside hospital in Mexico to our facility. The patient had widespread full-thickness necrotic wounds but no bullae or sloughing. Since the diagnosis was unclear at the time, it posed a significant challenge to make an appropriate anesthetic plan given the need for prolonged intubation after extensive burn debridement and grafting surgery. This case report highlights the importance of perioperative assessment, induction strategy, airway management, resuscitation, and pain control in an atypical TEN patient.
Keywords: burn resuscitation; fiberoptic intubation; ketamine and dexmedetomidine; pediatric burn pain management; toxic epidermal necrolysis (ten).
Copyright © 2025, Chau et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures


Similar articles
-
Toxic epidermal necrolysis after acute burn injury.Ann Burns Fire Disasters. 2018 Dec 31;31(4):266-270. Ann Burns Fire Disasters. 2018. PMID: 30983926 Free PMC article.
-
Treatment of extensive toxic epidermal necrolysis in children.Pediatrics. 2001 Nov;108(5):1162-8. doi: 10.1542/peds.108.5.1162. Pediatrics. 2001. PMID: 11694697
-
Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.Burns. 2018 May;44(3):603-611. doi: 10.1016/j.burns.2017.09.015. Epub 2017 Oct 10. Burns. 2018. PMID: 29029855
-
High risk and low prevalence diseases: Stevens Johnson syndrome and toxic epidermal necrolysis.Am J Emerg Med. 2024 Jul;81:16-22. doi: 10.1016/j.ajem.2024.04.001. Epub 2024 Apr 6. Am J Emerg Med. 2024. PMID: 38631147 Review.
-
[Advancement in the diagnosis and management of toxic epidermal necrolysis].Zhonghua Shao Shang Za Zhi. 2016 Jun;32(6):341-4. doi: 10.3760/cma.j.issn.1009-2587.2016.06.008. Zhonghua Shao Shang Za Zhi. 2016. PMID: 27321487 Review. Chinese.
References
-
- Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults. Hsu DY, Brieva J, Silverberg NB, Silverberg JI. J Invest Dermatol. 2016;136:1387–1397. - PubMed
-
- Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of macrolide antibiotics: a review of published cases. Pejčić AV. Int J Dermatol. 2021;60:12–24. - PubMed
-
- Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases. Villada G, Roujeau JC, Clérici T, Bourgault I, Revuz J. Arch Dermatol. 1992;128:50–53. - PubMed
-
- Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. French LE. Allergol Int. 2006;55:9–16. - PubMed
-
- Toxic epidermal necrolysis in early infancy. Scully MC, Frieden IJ. J Am Acad Dermatol. 1992;27:340–344. - PubMed
Publication types
LinkOut - more resources
Full Text Sources